MANE
Veradermics Inc

63
Mkt Cap
$2.28B
Volume
261,375.00
52W High
$62.56
52W Low
$17.00
Price
$59.14
MANE Fundamentals
Prev Close
$61.07
Open
$61.90
50D MA
$45.38
Beta
0.00
Avg. Volume
468,921.39
EPS (Annual)
-$0.7784
P/B
-44.19
Loading...
Loading...
News
all
press releases
Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting
Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological...
Business Wire·9h ago
News Placeholder
More News
News Placeholder
MANE's (NYSE:MANE) Quiet Period Will Expire on March 16th
MANE's (NYSE:MANE - Get Free Report) quiet period will end on Monday, March 16th. MANE had issued 15,077,647 shares in its IPO on February 4th. The total size of the offering was $256,319,999 based...
MarketBeat·10d ago
News Placeholder
MANE (NYSE:MANE) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of MANE (NYSE:MANE - Get Free Report) have received an average recommendation of "Moderate Buy" from the five research firms that are covering the firm, MarketBeat reports. One investment...
MarketBeat·13d ago
News Placeholder
MANE (NYSE:MANE) Upgraded by Zacks Research to "Hold" Rating
Zacks Research upgraded shares of MANE to a "hold" rating in a research report on Tuesday...
MarketBeat·13d ago
News Placeholder
Veradermics to Participate in Upcoming March Investor Conferences
Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological...
Business Wire·15d ago
News Placeholder
Jefferies Financial Group Upgrades MANE (NYSE:MANE) to Strong-Buy
Jefferies Financial Group upgraded shares of MANE to a "strong-buy" rating in a report on Monday...
MarketBeat·15d ago
News Placeholder
Citigroup Initiates Coverage on MANE (NYSE:MANE)
Citigroup assumed coverage on shares of MANE in a research note on Monday. They set a "buy" rating and a $85.00 price target for the company...
MarketBeat·16d ago
News Placeholder
MANE (NYSE:MANE) Now Covered by Analysts at Leerink Partners
Leerink Partners started coverage on MANE in a report on Monday. They set an "outperform" rating and a $75.00 target price for the company...
MarketBeat·16d ago
News Placeholder
NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell
NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell PR Newswire NEW YORK, Feb. 12, 2026 NYSE...
PR Newswire·1mo ago
News Placeholder
Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss
Veradermics, Incorporated (NYSE: MANE), a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics for common aesthetic and dermatological...
Business Wire·1mo ago
<
1
2
...
>

Latest MANE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.